William G. Wierda, MD, PhD, on CLL: How to Sequence Therapy

2017 NCCN Hematologic Malignancies Congress
Tweet this page

William G. Wierda, MD, PhD, of The University of Texas MD Anderson Cancer Center, discusses sequencing therapy in patients with relapsed/refractory CLL/SLL based on prior treatment and the presence of cytogenetic abnormalities.

Advertisement

Advertisement



Advertisement